Misonix, Inc. announced that it has entered into a definitive agreement with Solsys Medical, LLC to acquire Solsys in an all-stock transaction valued at approximately $97 million. Under the terms of the agreement, Misonix will issue approximately 5.7 million new shares to Solsys unitholders. In addition, the combined company's Board of Directors will consist of five members: three current Misonix directors, including Stavros Vizirgianakis, and two directors nominated by Solsys at closing. The combined company will remain headquartered in Farmingdale, NY with Solsys' operations and offices in Newport News, VA.